STUDY OF THE SAFETY OF LONG TERM TIAGABINE HCL ADMINISTRATION

这是一项开放标签、非比较、附加治疗的推广研究。 曾参与盐酸替加他滨癫痫治疗的患者 学习。然而，在研究过程中，伴随的AEDs可能会 逐渐停用，这样一些患者可能会出现 盐酸替加宾单一疗法。这项研究可以在以下任何地点进行： 在美国进行或已经进行盐酸替加他滨临床研究 各州。本研究的目的是确定该药的安全性。 盐酸替加宾作为癫痫的慢性治疗药物。

This is an open-label, noncomparative, add-on therapy, extension study in patients who have previously participated in a tiagabine HCL epilepsy study. However, during the course of the study concomitant AEDs may be gradually withdrawn so that some patients may be expected to acheive tiagabine HCL monotherapy. This study may be conducted at any site that is conducting or has conducted, tiagabine HCL clinical studies in the United States. THe objective of this study is to determine the safety of tiagabine HCl as chronic therapy for epilepsy.